Overview
Essure was a permanent birth control implant. Bayer resolved the U.S. Essure claims in August 2020 for approximately $1.6 billion (per Bayer press release); Essure sales had already ended in 2018 (per Bayer). The matter is archived — no new intake.
Companies involved
Settlement amounts
Bayer resolved U.S. Essure claims for ~$1.6 billion (per Bayer press release, Aug 2020). Claims were paid under the program; the device is no longer sold (per Bayer). No new intake.
Key dates
- August 1, 2020Bayer announces resolution of U.S. Essure claims — ~$1.6 billion (per Bayer press release)
- January 1, 2018Essure sales ended; device no longer sold in the U.S. (per Bayer and public reports)
Notable filings
No notable filings recorded yet. Docket entries are added from public court records as they appear.
FAQ
What is the Essure lawsuit about?
Essure was a permanent birth control implant. Claimants alleged injuries related to the device — including implant migration and related complications (per complaints). Bayer resolved the U.S. Essure claims in August 2020 (per Bayer press release).
How much did the settlement pay?
Bayer resolved the U.S. Essure claims for approximately $1.6 billion (per Bayer press release, August 2020).
Is Essure still being sold?
No — Essure sales ended in 2018 (per Bayer).
How were claims paid?
Claims were paid under the settlement program after the 2020 resolution (per Bayer press release). The claims process is closed; no new intake is accepted for this matter.
Why is this page archived?
The U.S. claims were resolved in August 2020 (per Bayer press release). We keep the record public as a reference for the device, the claims, and the outcome.
Case record — archived
This page is neutral reference material — not legal advice. The litigation for this matter has concluded, so case reviews are closed. For advice on your own situation, contact a licensed attorney in your country.